phenethyl isothiocyanate has been researched along with Breast Cancer in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, M; Zhang, T; Zhang, W | 1 |
| Mukherjee, S; Roy, M; Sarkars, R | 1 |
| Hahm, ER; Sakao, K; Singh, SV | 1 |
| Dave, RA; Morris, ME | 1 |
| Biswas, J; Mukherjee, S; Roy, M; Sarkar, R | 1 |
| Bui, LC; Cariou, K; Dodd, RH; Dupret, JM; Duval, R; Mathieu, C; Petit, E; Rodrigues-Lima, F; Xu, X | 1 |
| Ding, L; Kang, L; Wang, ZY | 1 |
| Brazeau, DA; Morris, ME; Telang, U | 1 |
| Cavell, BE; Packham, G; Syed Alwi, SS; Wang, XH | 1 |
| Kang, L; Wang, ZY | 1 |
| Cavell, BE; Morris, ME; Packham, G; Parry, BM; Syed Alwi, SS; Telang, U | 1 |
| Chung, FL; Govind, S; Mi, L; Roy, R; Sajankila, SP; Wang, X | 1 |
| Hahm, ER; Singh, SV | 1 |
| Ávila, R; Castilla, C; Flores, ML; Japón, MA; Ruiz-Borrego, M; Sáez, C | 1 |
| Cavell, BE; Donlevy, A; Packham, G; Syed Alwi, SS | 1 |
| Gupta, P; Srivastava, SK | 1 |
| Aras, U; Gandhi, YA; Masso-Welch, PA; Morris, ME | 1 |
1 review(s) available for phenethyl isothiocyanate and Breast Cancer
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of phenethyl isothiocyanate: implications in breast cancer prevention.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Female; Humans; Isothiocyanates; Rats | 2014 |
16 other study(ies) available for phenethyl isothiocyanate and Breast Cancer
| Article | Year |
|---|---|
Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1.
Topics: Anticarcinogenic Agents; Antigens, CD; Breast Neoplasms; Cadherins; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Neoplastic Stem Cells; Tumor Stem Cell Assay; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Targeting heat shock proteins by phenethyl isothiocyanate results in cell-cycle arrest and apoptosis of human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytochromes c; DNA Fragmentation; Heat-Shock Proteins; Humans; Isothiocyanates; MCF-7 Cells; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2013 |
In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Gene Knockdown Techniques; Humans; Isothiocyanates; Male; Mice; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; Vimentin | 2013 |
Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.
Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isothiocyanates; Neoplasm Invasiveness; Neoplasm Metastasis | 2016 |
Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens.
Topics: Acetylation; Amines; Arylamine N-Acetyltransferase; Breast Neoplasms; Carcinogens; DNA Adducts; Enzyme Inhibitors; Female; Humans; Isothiocyanates; Kinetics; Tumor Cells, Cultured | 2016 |
Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Female; Humans; Isothiocyanates; Reverse Transcriptase Polymerase Chain Reaction; Transfection | 2009 |
Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells.
Topics: Breast Neoplasms; Cell Line; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Mammary Glands, Human; Oligonucleotide Array Sequence Analysis; Sulfoxides; Thiocyanates | 2009 |
Inhibition of hypoxia inducible factor by phenethyl isothiocyanate.
Topics: Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isothiocyanates; Phosphorylation; Procollagen-Proline Dioxygenase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Von Hippel-Lindau Tumor Suppressor Protein | 2009 |
Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Genome, Human; Humans; Isothiocyanates; Leupeptins; Phosphorylation; Signal Transduction | 2010 |
In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Leukocytes, Mononuclear; Middle Aged; Nasturtium; Phosphoproteins; Phosphorylation; Phytotherapy; Pilot Projects; Plant Extracts; Plant Leaves; Transcription Factors | 2010 |
Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Butadienes; Caspase 3; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; HeLa Cells; Humans; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Uterine Cervical Neoplasms | 2011 |
Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Breast Neoplasms; Cell Line, Tumor; Female; Gene Silencing; Humans; Isothiocyanates; Membrane Proteins; Mice; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2 | 2012 |
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Isothiocyanates; M Phase Cell Cycle Checkpoints; Paclitaxel; Protein Binding | 2012 |
Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Glutathione; Humans; Isothiocyanates; MCF-7 Cells; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-bcl-2 | 2012 |
Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Mice; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Receptor, ErbB-2; RNA, Small Interfering; STAT3 Transcription Factor; Transgenes; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Chemopreventive and anti-angiogenic effects of dietary phenethyl isothiocyanate in an N-methyl nitrosourea-induced breast cancer animal model.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Breast Neoplasms; Diet; Disease Models, Animal; Female; Isothiocyanates; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tumor Burden | 2013 |